Sigmatic Sciences Information

Sigmatic Sciences, a proud Sapio Sciences Company, is dedicated to transforming R&D by unifying tools and autonomous processes in a single platform, enabling scientists to deliver better medicines, faster. We have created SigmaticOS, the only complete lab-in-the-loop platform for all scientists, allowing research to move from copilot to autopilot. SigmaticOS orchestrates 100+ agents across in silico workflows, lab automation, and model training with full traceability. By integrating scientific data from public, private and client sources with unlimited autonomous computation, SigmaticOS takes the pain out of drug discovery, closing the loop between computation and the bench, and putting human scientists into the driving seat. Sigmatic Sciences is led by a team with decades of experience in science, AI and bioinformatics and backed by one of Europe's leading healthcare investors, GHO Capital.